Acknowledgements
U-BIOPRED was supported by an Innovative Medicines Initiative Joint Undertaking (No.115010), resources from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in-kind contribution (www.imi.europa.eu). We thank the U-BIOPRED Project team for their contribution.
We acknowledge the important contribution of Dr Alan Lunt who sadly passed away on 1st June 2020 and dedicate this work in his memory.